Our Pricing

Wegovy Dose Chart UK: Complete Dosing Schedule Explained

Understanding the Wegovy dose chart UK is essential before starting semaglutide treatment. At Cured Pharmacy, all five Wegovy doses are available in stock, with transparent pricing from £79.00 and expert guidance from our UK-registered clinical team throughout your weight management journey.

Understanding the Wegovy Dose Chart UK: Complete Titration Schedule

Wegovy follows a carefully designed five-dose titration schedule approved by the MHRA for safe and effective weight management [1]. The gradual dose escalation minimises gastrointestinal side effects whilst allowing your body to adapt to semaglutide's appetite-regulating effects.

The complete Wegovy dosing schedule begins at 0.25mg weekly for month one, increasing to 0.5mg in month two, 1mg in month three, 1.7mg in month four, and reaching the maintenance dose of 2.4mg from month five onwards [1]. Each pen delivers four weekly doses at the prescribed strength, ensuring consistent medication delivery throughout the month.

Clinical data from the STEP trials demonstrated that patients who completed the full titration schedule experienced significantly fewer treatment discontinuations due to side effects compared to rapid dose escalation [2]. This gradual approach is why having all Wegovy doses available is critical for uninterrupted treatment success.

Why the Wegovy Titration Schedule Matters

The structured dose escalation serves two essential purposes: reducing the incidence of nausea, vomiting, and diarrhoea that can occur when GLP-1 receptor agonists are introduced too quickly, and allowing your body's natural satiety mechanisms to adjust gradually [1]. Patients who skip doses or accelerate the schedule without prescriber guidance often experience higher rates of gastrointestinal discomfort and treatment abandonment.

Wegovy Dosing Schedule: Month-by-Month Breakdown

Month one begins with the 0.25mg starter dose, administered once weekly on the same day each week. This lowest dose introduces semaglutide's mechanism whilst minimising side effects. Most patients notice subtle appetite changes during this phase, though significant weight loss typically begins in subsequent months [2].

Month two progresses to 0.5mg weekly, where many patients report their first noticeable reduction in food cravings and portion sizes. Month three advances to 1mg weekly, often coinciding with measurable weight loss on the scales. By month four at 1.7mg weekly, patients in the STEP-1 trial had achieved an average 9.6% body weight reduction [2].

The maintenance dose of 2.4mg weekly begins in month five and continues long-term. In clinical trials, patients on this dose achieved an average 14.9% body weight reduction over 68 weeks, with some individuals losing up to 20% of their starting weight [2]. Your UK prescriber will monitor your progress and may adjust timing if you experience persistent side effects.

What Happens If You Miss a Dose

If you miss your scheduled Wegovy injection and it has been fewer than five days, administer the missed dose as soon as you remember, then resume your normal weekly schedule. If more than five days have passed, skip the missed dose entirely and take your next dose on the regularly scheduled day [1]. Never double doses to compensate for missed injections, as this significantly increases the risk of gastrointestinal side effects.

All Wegovy Doses Available: Why Stock Continuity Matters

Wegovy supply interruptions have affected UK pharmacies throughout 2023 and 2024, with certain doses experiencing prolonged shortages. At Cured Pharmacy, we maintain stock of all five Wegovy doses to ensure patients can progress through the titration schedule without treatment gaps that compromise efficacy [3].

Treatment interruptions lasting more than two weeks may require restarting at a lower dose under prescriber guidance. Research indicates that maintaining consistent weekly dosing is associated with superior weight loss outcomes compared to interrupted treatment patterns [2]. When selecting an online pharmacy for Wegovy, confirming all-dose availability prevents frustrating delays during critical escalation phases.

Our pharmacy team monitors Wegovy stock levels daily and maintains relationships with multiple UK-licensed wholesalers to secure supply continuity. Patients receive automated notifications if their next scheduled dose is approaching and can track their treatment progression through their secure online account.

Wegovy Dose Chart UK: Clinical Evidence and Expected Outcomes

The STEP clinical trial programme established Wegovy's efficacy across diverse patient populations. STEP-1, the landmark trial involving 1,961 adults with obesity, demonstrated that 86.4% of participants on semaglutide 2.4mg achieved at least 5% weight loss, compared to 31.5% on placebo [2].

Importantly, weight loss followed a dose-dependent pattern throughout the titration schedule. Patients experienced gradual, sustained reductions rather than rapid initial drops, with the most significant losses occurring between months three and nine of treatment [2]. This timeline reinforces why completing the full dose escalation is essential for optimal outcomes.

Beyond weight reduction, trial participants experienced improvements in cardiovascular risk markers including blood pressure, lipid profiles, and HbA1c levels in those with type 2 diabetes [4]. These metabolic benefits emerged progressively as patients advanced through higher Wegovy doses, with maximum effect observed at the 2.4mg maintenance dose.

Realistic Weight Loss Expectations by Dose

During the initial 0.25mg and 0.5mg doses, expect modest weight changes averaging 2-4% of starting body weight as your appetite regulation adjusts. The 1mg and 1.7mg doses typically produce 6-10% weight reduction, whilst the 2.4mg maintenance dose achieved an average 14.9% loss in clinical trials over 68 weeks [2]. Individual results vary based on adherence, dietary choices, physical activity, and metabolic factors, which is why ongoing prescriber monitoring is required throughout treatment.

How to Buy Wegovy Online UK: The Cured Pharmacy Process

Purchasing Wegovy through Cured Pharmacy begins with a free online consultation that takes under three minutes to complete. Our UK-registered prescribers review your medical history, current medications, weight management goals, and any contraindications to semaglutide therapy. All prescription medications require this clinical assessment by a UK prescriber before dispensing.

If Wegovy is deemed clinically appropriate, your prescription is issued electronically to our dispensary where our GPhC-registered pharmacists prepare your medication for dispatch. Pricing is transparent and displayed upfront before consultation, with competitive UK rates and no hidden fees. Your first Wegovy pen ships in 100% discreet packaging via tracked courier.

Ongoing treatment includes regular prescriber check-ins to monitor weight loss progress, side effect management, and dose progression. Patients can message our clinical team through their secure account for questions about injection technique, managing nausea, or adjusting administration timing. Refills are streamlined through your patient portal, with automatic reminders before your current pen supply runs out.

Wegovy Side Effects and Dose-Related Management Strategies

The most common Wegovy side effects are gastrointestinal: nausea, diarrhoea, vomiting, constipation, and abdominal discomfort. These typically emerge or intensify when escalating to a new dose and often diminish within 2-4 weeks as your body adapts [1]. The gradual titration schedule exists specifically to minimise these effects.

If side effects are severe or persistent at a particular dose, your prescriber may recommend remaining at your current strength for an additional month before progressing, or implementing dietary modifications such as smaller, more frequent meals and avoiding high-fat foods. Staying well-hydrated and eating slowly can significantly reduce nausea intensity [1].

Rare but serious side effects include pancreatitis (severe abdominal pain radiating to the back), gallbladder problems, and changes in vision. Discontinue Wegovy and seek immediate medical attention if you experience these symptoms [1]. Your prescriber will screen for risk factors including personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 before prescribing.

When to Contact Your Prescriber About Side Effects

Contact your UK prescriber if you experience persistent vomiting preventing fluid intake, signs of dehydration, severe abdominal pain, visual changes, or allergic reactions including rash or difficulty breathing. Most gastrointestinal symptoms are manageable with dietary adjustments and typically resolve without dose modification, but your clinical team should assess any concerning or worsening symptoms to ensure safe treatment continuation.

Scientific References

1. Novo Nordisk. (2023). Wegovy 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, 2.4 mg solution for injection in pre-filled pen: Summary of Product Characteristics. Electronic Medicines Compendium. https://www.medicines.org.uk/emc/product/13799
2. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183
3. Medicines and Healthcare products Regulatory Agency. (2023). Supply update: Wegovy (semaglutide) pre-filled pens. GOV.UK. https://www.gov.uk/drug-safety-update/supply-update-wegovy-semaglutide-pre-filled-pens
4. Garvey, W. T., Batterham, R. L., Bhatta, M., et al. (2022). Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine, 28(10), 2083–2091. https://doi.org/10.1038/s41591-022-02026-4

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary. Weight loss outcomes depend on multiple factors including adherence, diet, physical activity, and individual metabolic response.